03/31/2025
3:57 PM | Acumen Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/27/2025
3:34 PM | Acumen Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2025
3:38 PM | Acumen Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025
6:24 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
8:19 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:14 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:16 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:18 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:06 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:17 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:31 PM | Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for ABOS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/21/2025
3:32 PM | Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:24 PM | Acumen Pharmaceuticals (Subject)
OConnell Daniel Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:25 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
6:57 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:00 PM | Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:02 PM | Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:09 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:48 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:53 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:55 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:16 PM | Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
4:54 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
4:59 PM | Acumen Pharmaceuticals (Subject)
Barton Russell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
5:04 PM | Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
4:24 PM | Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
4:27 PM | Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:42 PM | Acumen Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:48 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
4:26 PM | Acumen Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:40 PM | Acumen Pharmaceuticals (Issuer)
Drapkin Kimberlee C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:41 PM | Acumen Pharmaceuticals (Issuer)
Fountain Nathan B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:46 PM | Acumen Pharmaceuticals (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:49 PM | Acumen Pharmaceuticals (Issuer)
Stalfort John A III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:51 PM | Acumen Pharmaceuticals (Issuer)
Stoppel Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:36 PM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:47 PM | Acumen Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
6:35 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
11:15 PM | Acumen Pharmaceuticals (Filer)
| Form EFFECT | |
04/22/2024
3:33 PM | Acumen Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
3:30 PM | Acumen Pharmaceuticals (Filer)
| Form DEF 14A | |
Altucher: Turn $900 into $108,000 in just 12 months? (Ad) We are entering the final Trump Bump of our lives.
But the biggest returns will not be in the stock market. If I’m right about this (like I was before) a modest $900 investment… |
04/22/2024
3:31 PM | Acumen Pharmaceuticals (Filer)
| Form DEFA14A | |
